320 related articles for article (PubMed ID: 18850266)
1. Genetic variation in the natriuretic peptide system and heart failure.
Lanfear DE
Heart Fail Rev; 2010 May; 15(3):219-28. PubMed ID: 18850266
[TBL] [Abstract][Full Text] [Related]
2. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure.
Vassalle C; Andreassi MG; Prontera C; Fontana M; Zyw L; Passino C; Emdin M
Clin Chem; 2007 Nov; 53(11):1886-90. PubMed ID: 17890443
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.
Abuzaanona A; Lanfear D
Curr Heart Fail Rep; 2017 Dec; 14(6):536-542. PubMed ID: 29075957
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
Sangaralingham SJ; Kuhn M; Cannone V; Chen HH; Burnett JC
Cardiovasc Res; 2023 Feb; 118(18):3416-3433. PubMed ID: 36004816
[TBL] [Abstract][Full Text] [Related]
5. Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients.
Lanfear DE; Li J; Abbas R; She R; Padhukasahasram B; Gupta RC; Langholz D; Tang WH; Williams LK; Sabbah HN; Chow SL
J Cardiovasc Transl Res; 2015 Dec; 8(9):545-53. PubMed ID: 26589601
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptide system in the human retina.
Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
[TBL] [Abstract][Full Text] [Related]
7. Identification of a natriuretic peptide (NP) in cyclostomes (lamprey and hagfish): CNP-4 is the ancestral gene of the NP family.
Kawakoshi A; Hyodo S; Nozaki M; Takei Y
Gen Comp Endocrinol; 2006 Aug; 148(1):41-7. PubMed ID: 16740263
[TBL] [Abstract][Full Text] [Related]
8. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice.
Christoffersen C; Bartels ED; Nielsen LB
Eur J Clin Invest; 2006 Feb; 36(2):69-75. PubMed ID: 16436087
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptide family: new aspects.
Cea LB
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):87-98. PubMed ID: 15853696
[TBL] [Abstract][Full Text] [Related]
11. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
12. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides and therapeutic applications.
Lee CY; Burnett JC
Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional evolution of three cardiac natriuretic peptides.
Inoue K; Sakamoto T; Yuge S; Iwatani H; Yamagami S; Tsutsumi M; Hori H; Cerra MC; Tota B; Suzuki N; Okamoto N; Takei Y
Mol Biol Evol; 2005 Dec; 22(12):2428-34. PubMed ID: 16120806
[TBL] [Abstract][Full Text] [Related]
15. Genomic analyses and cloning of novel chicken natriuretic peptide genes reveal new insights into natriuretic peptide evolution.
Trajanovska S; Inoue K; Takei Y; Donald JA
Peptides; 2007 Nov; 28(11):2155-63. PubMed ID: 17905479
[TBL] [Abstract][Full Text] [Related]
16. Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.
Lanfear DE; Chow S; Padhukasahasram B; Li J; Langholz D; Tang WH; Williams LK; Sabbah HN
J Card Fail; 2014 Sep; 20(9):662-8. PubMed ID: 24983826
[TBL] [Abstract][Full Text] [Related]
17. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
19. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease.
Sergeeva IA; Christoffels VM
Biochim Biophys Acta; 2013 Dec; 1832(12):2403-13. PubMed ID: 23851052
[TBL] [Abstract][Full Text] [Related]
20. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
Nishikimi T; Kuwahara K; Nakao K
J Cardiol; 2011 Mar; 57(2):131-40. PubMed ID: 21296556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
